Although the molecular mechanism underlying SAP30 upregulation in breast tumors remains to be determined, our findings reveal that SAP30 is an independent prognostic factor for breast cancer and has a strong clinical relevance in patients with breast cancer. Here, SAP30 is linked to breast cancer.